Key Points
An experimental drug designed to block blood-clotting proteins may lower the risk of recurrent strokes, according to study...
While one in four people is estimated to have a stroke in their lifetime, many also go on to experience another stroke...
Previous research has shown that people with a deficiency of factor XIa protein known to play a role in blood coagulation, have lower rates of ischemic stroke, the most common type of stroke during which a blood clot blocks the flow of blood and oxygen to the brain...
After 90 days, investigators used MRI imaging and found that those participants who received 50-100mg of milvexian twice daily showed a slightly lower risk of recurrent stroke compared to placebo, according to the study...
We dont know that for sure, but it seems like it, and that has allowed us to pick a dose that hits that sweet spot of lowering the risk of stroke without raising the risk of bleeding too much, Bernstein said...
